Sat, Nov 23, 2024 | Updated 05:00 IST
Four drugs for COVID-19 appear to have little or no effect on reducing mortality: Solidarity trial results
Oct 17, 2020
New Delhi [India], October 17 : The interim analysis of WHO's Solidarity Trial has revealed that 4 repurposed drugs for COVID-19--remdesivir, hydroxychloroquine, lopinavir/ritonavir and...
Four repurposed drugs have no effect on reducing mortality in COVID-19 cases: WHO
Oct 16, 2020
New Delhi [India], October 16 : The interim analysis of World Health Organisation (WHO)'s Solidarity Trial has revealed that four repurposed drugs for COVID-19--remdesivir,...
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases
Apr 23, 2021
New Delhi [India], April 23 : The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin'...
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-19 infection
New Delhi [India], April 23 : Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the...
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated Interferon alpha-2b to treat COVID-19
Jul 17, 2020
Ahmedabad (Gujarat) [India], July 17 : Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against...
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical trial
May 05, 2020
New Delhi [India], May 5 : The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila,...
Neutrogena Uncomplicates Skincare to support women in their journey to get beautiful skin
Jun 21, 2022
Mylo Survey: 53.5 Per Cent of Women Choose Green Tea and Weight Loss Tea for Successful Weight Management
Sep 27, 2023
Ratan P. Watal appointed to the Board of TB Alliance
Mar 11, 2023
Related Videos
No Result Found